Skip to main content
Section 12: Review criteria for audit and quality improvement
Quality standards for osteoporosis
Primary Care
- Documentation of the proportion of postmenopausal women, and men age ≥50
years, registered with a general practice:
- With a fracture code, who have been assessed to determine whether their
fracture was a fragility (low-trauma) fracture
- With one or more risk factors for fragility fracture, who receive
formal fracture risk assessment.
- With a prior fragility fracture, who have had a DXA scan with the
result recorded.
- Calculated to be high or very high risk by FRAX assessment, who have
been offered drug treatment.
- With an incident hip fracture, those who receive pharmacological drug
therapy for osteoporosis within 16 weeks of their fracture.
- Who are prescribed pharmacological drug therapy for osteoporosis and
who have had confirmed adherence to osteoporosis therapy within the last 12 months.
- Who are prescribed pharmacological drug therapy for osteoporosis and
have had a 5-year and 10-year review.
- Who are prescribed denosumab, who have received timely (within 4 weeks
of due date) follow-up injection.
- Who are on oral glucocorticoids for ≥3 months who have had a fracture
risk assessment.
- With documented discussion of fracture risk assessment and a treatment
decision.
Fracture Liaison Services
- The Royal Osteoporosis Society (ROS) published in 2019 six key standards
for FLS with a corresponding timeline for the achievement of these six steps, with examples of audit and
evidence 297.
- The Royal College of Physicians Fracture Liaison Service (FLS) Database
National Audit (
https://www.rcplondon.ac.uk/projects/fracture-liaison-service-database-fls-db)
is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the Falls and Fragility
Fracture Audit Programme. The FLS-DB is included in the HQIP listing for national audits that must be
reported in each English hospital trust’s Quality Account, and is required by the Welsh Government for all
Health Boards in Wales. These form part of the National Clinical Audit Patient Outcomes Programme. All FLS
sites that treat fractures are eligible to participate. The FLS-DB sets out 11 Key Performance Indicators
(KPIs) which are designed to measure performance against technology assessments, guidance on osteoporosis
and clinical standards for FLSs from the NICE, the ROS and NOGG.
- The International Osteoporosis Foundation (IOF) Capture the Fracture Best
Practice Framework outlines 13 standards for FLS delivery with criteria and targets specified for bronze,
silver or gold levels of achievement (
https://www.capturethefracture.org/best-practice-framework).
DXA reporting
- The ROS published in 2019 six quality standards for DXA reporting with a
corresponding audit template 39.